The United States is working with a pharmaceutical company to develop a treatment for the 2019 Novel Coronavirus, using a class of drug that has boosted survival rates among Ebola patients, officials said Tuesday.   The partnership between the Department of Health and Human Services (HHS) and Regeneron will develop monoclonal antibodies to fight the … Continue reading US working with drug firm on new coronavirus treatment